A short TikTok review of the Ozpath app. Few details are given beyond the app's name, so tap through to see what it does and what the reviewer thinks.
Recap by typeshit. Video by TikTok on TikTok.
The surgeon says that after a 45 lb loss on a GLP-1, getting enough daily protein with a low appetite becomes the harder part.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
The writer cites a Gallup survey putting about 11 percent of Americans on GLP-1s and argues the real share is likely higher, and wants use discussed openly.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
A new 'In Discussion With' episode has pharmacist Sehar Shahid weighing in on obesity risk. The preview gives little beyond the topic.
Lilly reports its weight-loss drug boosted how well the psoriasis treatment Taltz worked when the two were given together.
Loading…